Drug was set to be dumped from UK’s list of approved medicines before deal was reached with pharmaceutical firm RocheAn expensive drug that could prolong the lives of women with advanced breast cancer by at least six months will remain on the list of medicines available on the NHS after the manufacturer agreed to lower the price.
Roche’s Kadcyla was one of a number of drugs set to be dumped from the Cancer Drugs Fund (CDF) list of medicines that the government pays for because the National Institute for Health and Care Excellence (kind) does not consider them to be cost-effective.Continue reading...
Source: theguardian.com